Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate [Phase 4]
A Phase 4 clinical trial evaluated diclofenac sodium topical gel to reduce injection-site discomfort in multiple sclerosis patients treated …
-
FDA approval · 2015-02-11FDA Approved: GABLOFEN — Supplemental Application (Piramal Critical Care Inc)
FDA approved a supplemental application for GABLOFEN (baclofen injection) submitted by Piramal Critical Care Inc.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency (CCSVI) [Phase 1, Phase 2]
Completion of Phase 1 and Phase 2 trials evaluating endovascular treatment for Chronic Cerebrospinal Venous Insufficiency in people with mul…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State [Phase 4]
This report documents a completed Phase 4 pharmacokinetic (PK) study of natalizumab (Tysabri) at steady state in patients with multiple scle…
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS [Phase 1]
A Phase 1 clinical trial evaluating VX15/2503 in patients with multiple sclerosis to assess safety, tolerability, and pharmacokinetics; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics Study With 2B3-201 in Healthy Subjects and Multiple Sclerosis(MS) Patients [Phase 1]
This Phase 1 trial assessed safety, pharmacokinetics and pharmacodynamics of 2B3-201 in healthy volunteers and multiple sclerosis patients a…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Low Fat Diet and Multiple Sclerosis [Phase 1]
Phase 1 clinical trial evaluating the effects of a low-fat diet in individuals with Multiple Sclerosis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetic study comparing BIIB017 (peginterferon beta-1a) and Rebif (interferon beta-1a) in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-02Clinical Trial Update: Adherence Trial With MS LifeLines ® Services
The Adherence Trial With MS LifeLines Services sponsored by EMD Serono has been terminated.
-
CLINICAL_TRIALS research · 2015-02-02Clinical Trial Update: Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis
Clinical trial update focusing on physical capacity and rehabilitation for patients with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Responsiveness and Minimal Clinical Important Difference of the Multiple Sclerosis Questionnaire for Physiotherapists
The update evaluates the responsiveness and the minimal clinically important difference (MCID) of the Multiple Sclerosis Questionnaire for P…
-
FDA approval · 2015-01-26FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for COPAXONE (glatiramer acetate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Promoting Physical Activity Behavior in Persons With Multiple Sclerosis [NA]
A completed clinical trial on promoting physical activity behavior in persons with multiple sclerosis; results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Depression and Fatigue in MS Patients Treated With Betaferon.
A completed clinical trial evaluated depression and fatigue in multiple sclerosis patients treated with Betaferon (interferon beta-1b) spons…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two [Phase 3]
A Phase 3 trial comparing alemtuzumab with Rebif (interferon beta-1a) in relapsing-remitting multiple sclerosis has completed, with results …
-
CLINICAL_TRIALS research · 2015-01-06Clinical Trial Update: Spinal Direct Current Stimulation Effects on Pain in Multiple Sclerosis [NA]
A clinical trial studying spinal direct current stimulation for pain in multiple sclerosis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis [Phase 3]
Sanofi reported the results of a Phase III trial comparing teriflunomide to placebo in patients with a first clinical symptom of multiple sc…
-
FDA approval · 2014-12-14FDA Approved: TIZANIDINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic tizanidine product from Sun Pharmaceutical Industries under an ANDA. Tizanidine is…
-
CLINICAL_TRIALS research · 2014-12-12Clinical Trial Update: Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis [Phase 1, Phase 2]
This clinical trial update describes body weight supported treadmill training for persons with Multiple Sclerosis in Phase 1 and Phase 2. Th…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating exercise as a strategy to treat cognitive dysfunction in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) [NA]
A completed clinical trial comparing 1.5T vs. 3T MRI protocols following treatment with glatiramer acetate in multiple sclerosis; results po…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Imaging Multiple Sclerosis Lesions Using Magnevist and Gadavist
A clinical trial investigating MRI imaging of multiple sclerosis lesions with Magnevist and Gadavist has been terminated.
-
FDA label_change · 2014-12-03FDA Approved: TECFIDERA — Supplemental Application (Biogen Inc.)
The FDA approved a supplemental application for TECFIDERA (dimethyl fumarate) from Biogen, resulting in labeling changes for the product. Th…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Nurse-Led Manualized Telephone Support Intervention [NA]
This clinical trial update reports on a completed study evaluating a nurse-led manualized telephone support intervention for people with mul…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months
A completed clinical trial evaluating the effects of Copaxone (glatiramer acetate) on retinal health in multiple sclerosis patients using op…